Skip to main content

Closed

OGN: Organon & Co. Financial Statements & Revenue | finqOS

Healthcare · Drug Manufacturers - General

52W Range

99thpctl

Volume

0.69×avg

Market Cap

3.56BUSD

P/E Ratio

16.9TTM

Div Yield

0.59%ann

Organon & Co.

OGNNew York Stock Exchange·USD·Closed

Organon & Co.

OGNNew York Stock Exchange·USD·Closed

$13.55

+0.00%

$13.55

+$0.00 (0.00%)

52W Range

99thpctl

Volume

0.69×avg

Mkt Cap

3.56BUSD

P/E

16.9TTM

Div Yield

0.59%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings